iSERA Lifesciences Associated Pages
iSERA Lifesciences FAQs
As of 07-2026, the promoter shareholding in iSERA Lifesciences stands at 58.63% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of iSERA Lifesciences is 0% and 0% respectively.
The retail shareholding of the iSERA Lifesciences is 41.37%.
Changes in shareholding patterns of iSERA Lifesciences can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of iSERA Lifesciences are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
